Your browser doesn't support javascript.
loading
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.
Wu, Xuan; Xia, Jiliang; Zhang, Jingyu; Zhu, Yinghong; Wu, Yangbowen; Guo, Jiaojiao; Chen, Shilian; Lei, Qian; Meng, Bin; Kuang, Chunmei; Feng, Xiangling; He, Yanjuan; Shen, Yi; Li, Xin; Qiu, Lugui; Li, Guancheng; Zhou, Wen.
Afiliação
  • Wu X; Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Xia J; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Zhang J; Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhu Y; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Wu Y; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Guo J; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Chen S; Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
  • Lei Q; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Meng B; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Kuang C; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Feng X; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • He Y; Key Laboratory of Carcinogenesis of the Chinese Ministry of Health and the Key Laboratory of Carcinogenesis and Cancer Invasion of Chinese Ministry of Education, Cancer Research Institute, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
  • Shen Y; Xiangya School of Public Health, Central South University, Changsha, Hunan, China.
  • Li X; Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Qiu L; Department of Orthopaedic Surgery, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Li G; Department of Hematology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhou W; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China.
Br J Haematol ; 190(1): 52-66, 2020 07.
Article em En | MEDLINE | ID: mdl-32037523

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoglicerato Desidrogenase / Bortezomib / Glutationa / Mieloma Múltiplo / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoglicerato Desidrogenase / Bortezomib / Glutationa / Mieloma Múltiplo / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China